supplementary fig 2 (Mendeley Ltd)
90
Structured Review
Mendeley Ltd
supplementary fig 2
Supplementary Fig 2, supplied by Mendeley Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/supplementary+fig+2/supplementary+fig+1/pmc12271416-212-2-11
Average 90 stars, based on 1 article reviews
Supplementary Fig 2, supplied by Mendeley Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/supplementary+fig+2/supplementary+fig+1/pmc12271416-212-2-11
Average 90 stars, based on 1 article reviews
supplementary fig 2 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Control:Article Title: Efficacy and Safety of the Oral Janus Kinase 1 Inhibitor Povorcitinib in Patients With Extensive Vitiligo in a Phase 2, Randomized, Double-Blinded, Dose-Ranging, Placebo-Controlled Study. Article Snippet: 213 214 Results 215 Patients 216 Between May 6, 2021, and May 24, 2023, 285 patients were screened, 171 randomized 217 (placebo, n=43; povorcitinib 15 mg, n=43; 45 mg, n=43; 75 mg, n=42), and 168 (98.2%) treated; 218 141 (82.5%) completed the 24-week Article Title: Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with atopic dermatitis: Results from TRuE-AD3, a phase 3, randomized double-blind study. Article Snippet: From the Univers Jolla, California Oregon Health State/Hershey Geffen School Angeles, Los Minnesota; A University of Dermatology Clinical Resea Clinical Resear Wilmington, D School of Med Funding sources: Medical writin and Andrew B cago, Illinois) a Prior presentatio Ruxolitinib Cre Dermatitis (TR European Aca Congress; Oct Demographics Atopic Derma (TRuE-AD3).. P Asthma & Im 23-26, 2024; W and Safety of Dermatitis Age Phase 3 Doub American Acad Annual Meetin Armstrong AW ment of Atop Baseline Clini Randomized P Academy of D 2024; San Di Ruxolitinib Cr Children Aged Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with atopic dermatitis: Results from TRuE-AD3, a phase 3, randomized double-blind study Article Title: Association between dermoscopic features and tumor thickness, diameter, age, and sex in acral melanoma: A cross-sectional study Article Snippet: Univariate and Article Title: Tumor-infiltrating lymphocyte scoring improves progression risk prediction in stage II melanoma: A retrospective cohort study. Article Snippet: Combining TIL score with AJCC substage refines prognostic accuracy Stratification by TIL score and AJCC substage identified a higher-risk group (stage IIB and IIC melanomas 1 melanomas with nonbrisk TILs), and a lower-risk group (stage IIA melanomas 1 melanomas with absent or brisk TILs) (Supplementary Fig 2, available via Article Title: Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic dermatitis. Article Snippet: Results: Both therapies improved skin barrier function, with abrocitinib achieving superior reductions in transepidermal water loss in nonlesional skin (P = .0168).. Proteomic analysis revealed differentially expressed proteins predominantly associated with ceramide metabolism, neurobiology, and keratinocyte biology in AD.. Key potential biomarkers were identified: arginase 1 and proteasome subunit beta type-6 in lesional skin, alongside grancalcin and phospholipase D3 in nonlesional skin. Article Title: Digital clubbing in cystic fibrosis: The nails as clues to advanced disease. Article Snippet: Fig 1.. Digital clubbing in a patient with cystic fibrosisrelated vasculitis.. A 23-year-old female patient with forced expiratory volume in 1 second of 16% and oxygen use requirement prior to lung transplantation for cystic fibrosis. Article Title: Differential time series analysis shows deceleration in melanoma mortality prior to the widespread use of highly effective therapies. Article Snippet: Results: Melanoma mortality rates have been significantly decelerating since the 1970s in both the U.S. (P\ .0001) and Australia (P = .0021).. Zero acceleration occurred around 2001 (95% CI: 1996, 2008) for the U.S. and 2004 (95% CI: 1999, 2011) for Australia.. Male mortality rates decelerated 3x-4x faster than females in both countries. Cream:Article Title: Efficacy and Safety of the Oral Janus Kinase 1 Inhibitor Povorcitinib in Patients With Extensive Vitiligo in a Phase 2, Randomized, Double-Blinded, Dose-Ranging, Placebo-Controlled Study. Article Snippet: 213 214 Results 215 Patients 216 Between May 6, 2021, and May 24, 2023, 285 patients were screened, 171 randomized 217 (placebo, n=43; povorcitinib 15 mg, n=43; 45 mg, n=43; 75 mg, n=42), and 168 (98.2%) treated; 218 141 (82.5%) completed the 24-week Article Title: Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with atopic dermatitis: Results from TRuE-AD3, a phase 3, randomized double-blind study. Article Snippet: From the Univers Jolla, California Oregon Health State/Hershey Geffen School Angeles, Los Minnesota; A University of Dermatology Clinical Resea Clinical Resear Wilmington, D School of Med Funding sources: Medical writin and Andrew B cago, Illinois) a Prior presentatio Ruxolitinib Cre Dermatitis (TR European Aca Congress; Oct Demographics Atopic Derma (TRuE-AD3).. P Asthma & Im 23-26, 2024; W and Safety of Dermatitis Age Phase 3 Doub American Acad Annual Meetin Armstrong AW ment of Atop Baseline Clini Randomized P Academy of D 2024; San Di Ruxolitinib Cr Children Aged Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with atopic dermatitis: Results from TRuE-AD3, a phase 3, randomized double-blind study Article Title: Association between dermoscopic features and tumor thickness, diameter, age, and sex in acral melanoma: A cross-sectional study Article Snippet: Univariate and Article Title: Tumor-infiltrating lymphocyte scoring improves progression risk prediction in stage II melanoma: A retrospective cohort study. Article Snippet: Combining TIL score with AJCC substage refines prognostic accuracy Stratification by TIL score and AJCC substage identified a higher-risk group (stage IIB and IIC melanomas 1 melanomas with nonbrisk TILs), and a lower-risk group (stage IIA melanomas 1 melanomas with absent or brisk TILs) (Supplementary Fig 2, available via Article Title: Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic dermatitis. Article Snippet: Results: Both therapies improved skin barrier function, with abrocitinib achieving superior reductions in transepidermal water loss in nonlesional skin (P = .0168).. Proteomic analysis revealed differentially expressed proteins predominantly associated with ceramide metabolism, neurobiology, and keratinocyte biology in AD.. Key potential biomarkers were identified: arginase 1 and proteasome subunit beta type-6 in lesional skin, alongside grancalcin and phospholipase D3 in nonlesional skin. Article Title: Digital clubbing in cystic fibrosis: The nails as clues to advanced disease. Article Snippet: Fig 1.. Digital clubbing in a patient with cystic fibrosisrelated vasculitis.. A 23-year-old female patient with forced expiratory volume in 1 second of 16% and oxygen use requirement prior to lung transplantation for cystic fibrosis. Article Title: Differential time series analysis shows deceleration in melanoma mortality prior to the widespread use of highly effective therapies. Article Snippet: Results: Melanoma mortality rates have been significantly decelerating since the 1970s in both the U.S. (P\ .0001) and Australia (P = .0021).. Zero acceleration occurred around 2001 (95% CI: 1996, 2008) for the U.S. and 2004 (95% CI: 1999, 2011) for Australia.. Male mortality rates decelerated 3x-4x faster than females in both countries. |